Literature DB >> 29629756

An Emerging Pathway of Doxorubicin Cardiotoxicity Mediated through CYP2J2.

William R Arnold, Aditi Das.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29629756      PMCID: PMC5928007          DOI: 10.1021/acs.biochem.8b00337

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  5 in total

1.  Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.

Authors:  Garrett J Gross; Anna Hsu; John R Falck; Kasem Nithipatikom
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

2.  Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.

Authors:  William R Arnold; Javier L Baylon; Emad Tajkhorshid; Aditi Das
Journal:  Biochemistry       Date:  2017-12-12       Impact factor: 3.162

Review 3.  The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.

Authors:  Xizhen Xu; Xin A Zhang; Dao Wen Wang
Journal:  Adv Drug Deliv Rev       Date:  2011-04-06       Impact factor: 15.470

4.  Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.

Authors:  Yunfang Zhang; Haitham El-Sikhry; Ketul R Chaudhary; Sri Nagarjun Batchu; Anooshirvan Shayeganpour; Taibeh Orujy Jukar; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Page Myers; Douglas C Rouse; Julie Foley; Abraham Nyska; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

5.  Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.

Authors:  Y Singh; L Ulrich; D Katz; P Bowen; G Krishna
Journal:  Toxicol Appl Pharmacol       Date:  1989-08       Impact factor: 4.219

  5 in total
  1 in total

Review 1.  Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.

Authors:  Theresa Aliwarga; Eric A Evangelista; Nona Sotoodehnia; Rozenn N Lemaitre; Rheem A Totah
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.